ArticleBiomedical reports2025
Impact of vascular risk factors on endovascular mechanical thrombectomy outcomes in patients with stroke.
Article in Biomedical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endovascular mechanical thrombectomy (MT) is a recommended treatment for acute ischemic stroke due to large vessel occlusion (LVO). The objective of the present study was to evaluate the impact of vascular risk factors on the outcome of MT outcomes in patients with stroke with LVO and to determine the prevalence of structural epilepsy in these patients. This was a retrospective cohort study involving patients with stroke between 20 and 80 years of age with LVO who underwent MT. The clinical outcomes post-MT were assessed using the Modified Thrombolysis in Cerebral Infarction score. A total of 56 individuals were included in the study, with a structural epilepsy prevalence of 14.29%. Patients who received intravenous tissue plasminogen activator (TPA) in addition to MT were less likely to develop structural epilepsy (P=0.041). A substantial number of patients (85.8%, combined Grades 3 and 2B) achieved successful reperfusion. The significant risk factors for hemorrhagic transformation include age [odds ratio (OR), 2.5; 95% CI: 1.8-3.6; P=0.001], hypertension (OR, 3; 95% CI: 2.2-4.1; P<0.001), diabetes (OR, 1.8; 95% CI: 1.2-2.7; P=0.008), heart failure (OR, 1.5; 95% CI: 1.0-2.2; P=0.050) and cardiac thrombus (OR, 2.0; 95% CI: 1.3-3.1; P=0.005). Age was a significant predictor, with patients aged 65 years or younger having an OR of 2.3 (95% CI: 1.5-3.5, P=0.002). In conclusion, the present study provides valuable insights into the impact of vascular risk factors on the outcomes of MT in patients with stroke with LVO and highlights key predictors of post-procedural complications, including structural epilepsy and hemorrhagic transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.